An essential role for the Zn2+ transporter ZIP7 in B cell development (2019)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41590-018-0295-8
PubMed Identifier: 30718914
Publication URI: http://europepmc.org/abstract/MED/30718914
Type: Journal Article/Review
Parent Publication: Nature Immunology
Issue: 3
ISSN: 1529-2908